Halozyme Therapeutics, Inc. (HALO)
62.64
+0.77
(+1.24%)
USD |
NASDAQ |
Dec 10, 16:00
62.73
+0.09
(+0.14%)
After-Hours: 19:13
Halozyme Therapeutics Price: 62.64 for Dec. 10, 2025
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Merck & Co., Inc. | 97.58 |
| ANI Pharmaceuticals, Inc. | 82.02 |
| Bristol Myers Squibb Co. | 51.20 |
| Twist Bioscience Corp. | 32.77 |
| Aurinia Pharmaceuticals, Inc. | 15.49 |
Price Related Metrics
| PE Ratio | 13.17 |
| PS Ratio | 6.327 |
| PEG Ratio | 0.2293 |
| Price to Book Value | 14.62 |
| Price to Free Cash Flow | 13.05 |
| Earnings Yield | 7.59% |
| Market Cap | 7.366B |
| PEGY Ratio | 0.2293 |
| Operating PE Ratio | 10.66 |
| Normalized PE Ratio | 13.17 |